Friday, May 1, 2026

Chong Kun Dang Wins European Phase 1 Approval for Dupixent Biosimilar: Advancing CKD-706’s Global Development

Chong Kun Dang's CKD-706 biosimilar for Dupixent received Phase 1 trial approval in Europe, aiming to expand treatment options for inflammatory diseases.

Satellite Imagery Shows China Preparing to Open Large-Scale Customs Facility Near North Korea

China plans to open a customs facility in Hunchun, enhancing trade with North Korea and countering ties with Russia.

Tag: Anthony Kim

No posts to display

Top News

- Our Sponsors Ad -

Follow us